Deciphera Pharmaceuticals DCPH
$ 25.59
0.0%
Annual report 2023
added 02-07-2024
Deciphera Pharmaceuticals Financial Ratios 2011-2024 | DCPH
Annual Financial Ratios Deciphera Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.2 | -6.9 | -1.5 | -9.2 | -14.2 | -9.3 | -8.8 | - | - | - | - | - | - |
P/S |
7.3 | 9.3 | 4.7 | 58.0 | 109.6 | - | - | - | - | - | - | - | - |
EPS |
-2.3 | -2.4 | -5.2 | -4.8 | -4.5 | -2.8 | -3.0 | -2.2 | -4.7 | - | - | - | - |
EV (Enterprise Value) |
1.24 B | 1.29 B | 486 M | 2.4 B | 2.69 B | 674 M | 261 M | 141 M | 116 M | - | - | - | - |
EBITDA per Share |
-2.46 | -2.38 | -5.11 | -4.82 | -4.66 | -2.93 | -3.02 | - | - | - | - | - | - |
EV/EBITDA |
-1.5 | -8.9 | -13.1 | -6.2 | -4.9 | - | - | - | - | - | - | ||
PEG |
- | 1.4 | 0.24 | -1.64 | 0.08 | - | - | - | - | - | - | ||
P/B |
3.4 | 3.6 | 1.5 | 4.5 | 5.0 | 3.3 | 2.4 | - | - | - | - | - | - |
P/CF |
-8.2 | -8.1 | -1.9 | -10.2 | -17.8 | -10.6 | -11.9 | - | - | - | - | - | - |
ROE % |
-55.55 | -52.37 | -98.44 | -49.02 | -35.18 | -35.66 | -27.33 | - | - | - | - | - | - |
ROA % |
-41.16 | -39.41 | -69.84 | -41.48 | -30.89 | -31.64 | -25.26 | - | - | - | - | - | - |
ROCE % |
-60.12 | -53.48 | -98.48 | -49.88 | -35.69 | -35.55 | -27.49 | - | - | - | - | - | - |
Current Ratio |
3.9 | 4.0 | 3.4 | 6.5 | 9.9 | 13.2 | 14.3 | - | - | - | - | - | - |
DSO |
60.8 | 58.6 | 65.5 | 60.3 | - | - | - | - | - | - | - | - | - |
DIO |
2042.7 | 721.8 | 1235.0 | 4636.3 | - | - | - | - | - | - | - | - | - |
DPO |
2204.9 | 660.5 | 1583.4 | 25860.7 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
2103.4 | 780.4 | 1300.5 | 4696.6 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-101.5 | 119.8 | -282.9 | -21164.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Deciphera Pharmaceuticals
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.58 | -0.57 | -0.6 | - | -0.55 | -0.6 | -0.8 | - | -1.37 | -1.21 | -1.06 | -1.1 | -1.13 | -1.2 | -1.36 | -1.31 | -1.28 | -0.56 | -1.25 | -0.86 | -0.65 | -0.65 | -0.66 | -0.62 | -1.04 | -0.91 | -0.66 | -0.74 | -0.52 | -0.51 | -0.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.64 | - | -0.54 | -0.61 | -0.79 | - | -1.33 | -1.22 | -1.05 | -1.09 | -1.11 | -1.22 | -1.4 | -1.36 | -1.32 | -0.6 | -1.29 | -0.9 | -0.68 | -0.66 | -0.67 | -0.62 | -1.04 | -0.91 | -0.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-47.79 | -46.31 | -44.94 | -39.42 | -60.40 | -69.87 | -75.01 | -96.39 | -107.93 | -135.97 | -169.22 | -158.59 | -159.35 | -145.53 | -131.70 | -117.87 | -117.11 | -117.60 | -118.09 | -47.22 | -46.50 | -38.16 | -29.82 | -92.85 | -75.90 | -48.56 | -21.22 | 6.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-37.57 | -36.65 | -39.29 | -33.37 | -49.89 | -45.20 | -58.23 | -79.94 | -89.71 | -114.68 | -143.13 | -134.21 | -135.25 | -124.66 | -114.07 | -103.49 | -102.92 | -103.69 | -104.45 | -41.89 | -41.66 | -35.27 | -28.87 | -85.79 | -90.31 | -65.05 | -39.78 | -14.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-51.22 | -49.17 | -46.93 | -40.09 | -61.03 | -69.96 | -74.93 | -48.95 | -60.54 | -51.37 | -48.26 | -49.88 | -51.17 | -50.08 | -41.60 | -36.73 | -35.94 | -34.51 | -38.31 | -37.18 | -36.15 | -33.53 | -31.33 | -27.69 | -10.53 | -3.90 | 1.91 | 6.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.3 | 4.8 | 5.0 | 4.0 | 4.7 | - | 3.4 | 3.4 | 4.7 | 5.8 | 6.5 | 6.5 | 6.5 | 6.5 | 6.5 | 8.2 | 8.2 | 8.2 | 8.2 | 8.9 | 8.9 | 8.9 | 8.9 | 13.2 | 13.2 | 13.2 | 13.2 | 9.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
53.5 | 54.4 | 61.2 | - | 29.5 | 32.5 | 68.3 | - | 72.0 | 78.2 | 64.8 | 65.1 | 82.1 | 178.8 | 10225.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
1860.8 | 13416.1 | 4309.0 | - | 261.0 | 497.8 | 4031.2 | - | 769.2 | 547.4 | 2631.9 | - | 5795.4 | 65198.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1407.2 | 9990.3 | 3579.1 | - | 174.6 | 451.5 | 3694.3 | - | 1369.5 | 927.8 | 4976.2 | - | 12478.9 | 140388.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
1914.2 | 13470.5 | 4370.2 | - | 290.5 | 530.3 | 4099.5 | - | 841.2 | 625.6 | 2696.6 | 65.1 | 5877.5 | 65377.0 | 10225.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
507.0 | 3480.2 | 791.1 | - | 115.9 | 78.8 | 405.2 | - | -528.3 | -302.2 | -2279.6 | 65.1 | -6601.5 | -75011.2 | 10225.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency